Your browser doesn't support javascript.
loading
The role of IL-17, IL-23 and IL-31, IL-33 in allergic skin diseases.
Topal, Fatih A; Zuberbier, Torsten; Makris, Michael P; Hofmann, Maja.
Afiliação
  • Topal FA; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Campus Benjamin-Franklin, Berlin, Germany.
  • Zuberbier T; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Campus Benjamin-Franklin, Berlin, Germany.
  • Makris MP; Allergy Unit 'D. Kalogeromitros', 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, University General Hospital 'ATTIKON', Athens, Greece.
  • Hofmann M; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Curr Opin Allergy Clin Immunol ; 20(4): 367-373, 2020 08.
Article em En | MEDLINE | ID: mdl-32590505
ABSTRACT
PURPOSE OF REVIEW Allergic skin diseases such as urticaria, atopic dermatitis and allergic contact dermatitis are among the most common skin diseases with severe socioeconomic consequences. The pathogenesis of allergic skin diseases is complex. This review provides an overview of cytocines IL-17, IL-23, IL-31 and IL-33. RECENT

FINDINGS:

Current research results show a variety of immunological processes in the pathogenesis of the allergic skin diseases, including the role of cytokines. In addition to the Th1 and Th2 immune response, the immune response via Th17 is becoming increasingly important in allergic skin diseases but also the cytokines IL-23, IL-31 and IL-33 have been discussed in the literature recently. Different cytokines promote in a kind of orchestra the different symptoms seen in the different allergic skin diseases, including pruritus, dermatitis, mast cell mediator release and inflammation.

SUMMARY:

We are still in the early stages of understanding pathophysiology of allergic skin diseases and the role of various cytokines in the immune system. With the development of targeted antibodies against the proinflammatory cytokines, the variety of normal therapeutic options can be expected to evolve.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Dermatite Alérgica de Contato / Dermatite Atópica / Imunossupressores Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Dermatite Alérgica de Contato / Dermatite Atópica / Imunossupressores Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article